In gastric cancer, although studies have shown that PTK7 is overexpressed, both studies confirmed that its expression is associated with better OS and disease-free survival (DFS) (58, 59), which suggests that PTK7 may be a double-edged sword in gastric cancer treatment. The gene discussed is PTK7; the disease is gastric cancer.